The world’s richest man and American billionaire, Elon Musk, said on February 19 that the first human patient of his neuroscience startup Neuralink, to be implanted with the company’s brain chip, appears to have fully recovered and is able to control a computer mouse with his thoughts.
According to Reuters, Musk stated on the social media platform X Neuralink is now trying to get patients to click as many mouse buttons as possible.
Neuralink’s Precision Robotic Implantation Brain-Computer Interface (PRIME) research. Successfully completed the world’s first human patient implantation in January of this year. The main purpose is to analyze motion signals from brain activity. The subsequent PRIME trial will last for six years, but almost no relevant information has been made public, showing a deep lack of transparency. Details about the world’s first human patient to receive a Neuralink brain-computer interface are still scarce.
Neuralink said that this research uses robots to surgically implant a brain-computer interface into the patient’s brain to control areas of movement intention, and the initial goal is to enable people to control the computer mouse pointer or keyboard with their thoughts.
Although Musk has lofty ambitions for the development of Neuralink, stating that it will promote the rapid implantation of chip devices to treat diseases such as obesity, autism, depression and schizophrenia; while Neuralink was valued at about $5 billion last year, it has faced repeated calls to review its security protocols.
About Author
